News
Reduced monthly costs for uninsured patients still amount to around $500. That can put the drugs out of reach for many.
Pharmacy benefit manager CVS Caremark drops Zepbound coverage, estimating 10-15% savings while Eli Lilly offers self-pay ...
Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging. The medications still amount to around $500 per month for those without ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results